Belite Bio Announces UKs Medicines and Healthcare Products Regulatory Agency Agrees to Conditional Marketing Authorization Application Based on Interim Analysis Results for the Treatment of Stargardt Disease with Tinlarebant
November 02, 2025 09:00 ET Â | Source: Belite Bio, Inc MHRA response…
NTG Nordic Transport Group A/S – Q3 2025 Conference Call
October 10, 2025 04:00 ET Â | Source: NTG Nordic Transport Group A/S…
Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…
Avicanna Announces Change in CFO
September 12, 2025 18:00 ET Â | Source: Avicanna Inc. TORONTO, Sept. 12,…
Aja Health And Wellness Inc. Provides Update on Delay in Filing Financial Statements
September 12, 2025 19:34 ET Â | Source: Aja Health and Wellness Inc.…
SANY Reports Strong First Half 2025 Results, Delivering Profitable Growth
Revenue Up 15% to $6.24 Billion; Operating Cash Flow Up 20% to…
ZETADISPLAY AB (publ) INTERIM REPORT 1 APRIL 30 JUNE 2025 (Q2)
Q2 Interim report April – June 2025 for ZetaDisplay AB (publ) is…
Angelalign Technology Announces First-Half 2025 Results While Increasing Investments in Legal, Supply Chain and Data Security
SAN CLEMENTE, Calif., Aug. 26, 2025 /PRNewswire/ -- Angelalign Technology Inc. ("Angel"…
41/2025Trifork Group: Interim report for the quarter and half-year ending 30 June 2025
Company announcement no. 41/2025Schindellegi, Switzerland – 19 August 2025 Interim Financial Report…